Merck plans large outpatient trial of COVID-19 pill, stops study in hospitalized patients
(Reuters) – Merck & Co Inc on Thursday said it plans a large study of what could become the first pill to target the coronavirus in people at risk of severe COVID-19, but will no longer pursue use of the experimental antiviral drug in hospitalized patients.
